Dubuque Bank & Trust CO Crispr Therapeutics Ag Transaction History

Dubuque Bank & Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$53.19 - $79.24 $152,655 - $227,418	-2,870 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$70.09 - $111.29 $210 - $333	-3 Reduced 0.1%	2,870 $217,000
Q3 2020 Oct 28, 2020	BUY	$78.5 - $100.64 $225,530 - $289,138	2,873 New	2,873 $240,000
Q2 2019 Jul 10, 2019	SELL	$35.45 - $48.2 $101,847 - $138,478	-2,873 Closed	0 $0
Q1 2019 Apr 02, 2019	BUY	$28.02 - $40.87 $40,572 - $59,179	1,448 Added 101.61%	2,873 $103,000
Q3 2017 Oct 13, 2017	BUY	$16.75 - $20.66 $23,868 - $29,440	1,425	1,425 $25,000

510

57.7M

1.74M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.82B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Dubuque Bank & Trust CO with notifications on news.